Our Affiliate System

We are building one organization with affiliates in two regions. Our parent company, now known as Prisma Health, supports both affiliates with overall direction and leadership as we continue to align. We will soon share one brand across the entire organization to better reflect this. The rebranded Palmetto Health-USC Medical Group will continue to operate as a joint venture between the Midlands affiliate and the USC School of Medicine.

Learn more
We are becoming Prisma Health in early 2019

Testicular Cancer


Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas of the body. Cancer that starts in the testicles is called testicular cancer.

With timely diagnosis, testicular cancer is most likely treatable and most often curable. It is the most common cancer in men 15 to 34 years old. Still, it is fairly rare. About 8,850 men will be diagnosed with testicular cancer in the U.S. this year. The risk of death from testicular cancer is small. About 410 men will die of testicular cancer in the U.S. this year.

Risk Factors

  • An undescended testicle
  • Family history of testicular cancer
  • HIV infection
  • Carcinoma in situ of the testicle
  • Having had testicular cancer before
  • Being of a certain race/ethnicity- The risk of testicular cancer among white men is about 4 to 5 times that of black men and that of Asian-American men.
  • Body size


Signs of a testicular tumor are:
• a painless lump in the testicle (the most common sign)
• a feeling of weight in the scrotum
• swelling of the testicle.(with or without pain)
• pain or a dull ache in the testicle, scrotum or groin.


Depending on the type and stage of the cancer and other factors, treatment options for testicular cancer can include:

  • Surgery
  • Radiation therapy
  • Chemotherapy (chemo)
  • High-dose chemotherapy and stem cell transplant